Publicacións nas que colabora con Verónica López López (32)

2018

  1. E74-Like Factor (ELF3) and Leptin, a Novel Loop between Obesity and Inflammation Perpetuating a Pro-Catabolic State in Cartilage

    Cellular Physiology and Biochemistry, Vol. 45, Núm. 6, pp. 2401-2410

  2. Oleocanthal Inhibits Catabolic and Inflammatory Mediators in LPS-Activated Human Primary Osteoarthritis (OA) Chondrocytes Through MAPKs/NF-κB Pathways

    Cellular Physiology and Biochemistry, Vol. 49, Núm. 6, pp. 2414-2426

2017

  1. Adipokines induce pro-inflammatory factors in activated Cd4+ T cells from osteoarthritis patient

    Journal of Orthopaedic Research, Vol. 35, Núm. 6, pp. 1299-1303

  2. Corticoids synergize with IL-1 in the induction of LCN2

    Osteoarthritis and Cartilage, Vol. 25, Núm. 7, pp. 1172-1178

2016

  1. E74-like factor 3 and nuclear factor-κB regulate lipocalin-2 expression in chondrocytes

    Journal of Physiology, Vol. 594, Núm. 21, pp. 6133-6146

  2. The novel adipokine progranulin counteracts IL-1 and TLR4-driven inflammatory response in human and murine chondrocytes via TNFR1

    Scientific Reports, Vol. 6

2015

  1. Basic Aspects of Adipokines in Bone Metabolism

    Clinical Reviews in Bone and Mineral Metabolism, Vol. 13, Núm. 1, pp. 11-19

  2. Choosing the right chondrocyte cell line: Focus on nitric oxide

    Journal of Orthopaedic Research, Vol. 33, Núm. 12, pp. 1784-1788

  3. IL-36α: A novel cytokine involved in the catabolic and inflammatory response in chondrocytes

    Scientific Reports, Vol. 5

  4. Identification of novel adipokines in the joint.Differential expression in healthy and osteoarthritis tissues

    PLoS ONE, Vol. 10, Núm. 4

  5. New drugs from ancient natural foods. Oleocanthal, the natural occurring spicy compound of olive oil: A brief history

    Drug Discovery Today

  6. SERPINE2 inhibits IL-1α-induced MMP-13 expression in human chondrocytes: Involvement of ERK/NF-κB/AP-1 pathways

    PLoS ONE, Vol. 10, Núm. 8

2014

  1. Adipokines as drug targets in joint and bone disease

    Drug Discovery Today, Vol. 19, Núm. 3, pp. 241-258

  2. Adipokines, metabolic syndrome and rheumatic diseases

    Journal of Immunology Research, Vol. 2014

  3. Adiponectin and leptin: New targets in inflammation

    Basic and Clinical Pharmacology and Toxicology, Vol. 114, Núm. 1, pp. 97-102

  4. An update on leptin as immunomodulator

    Expert Review of Clinical Immunology, Vol. 10, Núm. 9, pp. 1165-1170

  5. Bone metabolism and adipokines: Are there perspectives for bone diseases drug discovery?

    Expert Opinion on Drug Discovery, Vol. 9, Núm. 8, pp. 945-957

  6. Differential expression of adipokines in infrapatellar fat pad (IPFP) and synovium of osteoarthritis patients and healthy individuals

    Annals of the Rheumatic Diseases

  7. Endogenous cannabinoid anandamide impairs cell growth and induces apoptosis in chondrocytes

    Journal of Orthopaedic Research, Vol. 32, Núm. 9, pp. 1137-1146

  8. NUCB2/nesfatin-1: A new adipokine expressed in human and murine chondrocytes with pro-inflammatory properties, an in vitro study

    Journal of Orthopaedic Research, Vol. 32, Núm. 5, pp. 653-660